News Release
Strictly embargoed until 07:00 2 May 2012
AVON RUBBER p.l.c.
("Avon", the "Group" or the "Company")
Unaudited interim results for the six months ended 31 March 2012
|
31 March 2012 |
31 March 2011 |
|
£Millions |
£Millions |
|
|
|
REVENUE |
49.6 |
48.0 |
|
|
|
EARNINGS BEFORE INTEREST, TAXATION, DEPRECIATION AND AMORTISATION |
7.2 |
7.1 |
|
|
|
OPERATING PROFIT |
5.0 |
4.8 |
|
|
|
PROFIT BEFORE TAXATION |
4.6 |
4.4 |
|
|
|
PROFIT FOR THE PERIOD |
3.3 |
3.1 |
|
|
|
NET DEBT |
9.8 |
13.9 |
|
|
|
BASIC EARNINGS PER SHARE |
11.3p |
10.8p |
FINANCIAL HIGHLIGHTS
· Profit before tax up 6%
· Earnings per share up 5%
· Interim dividend of 1.2p per share up 20%
· Net debt reduced to £9.8m from £11.8m at 30 September 2011
· Lower interest costs and effective tax rate
· 126% conversion of operating profit to operating cash inflow
OPERATIONAL HIGHLIGHTS
· Growth in DoD respirator sales and order book secure for the next 12 months
· Continued growth in non-DoD Protection & Defence order intake, including a £14.7m order for 2013 and 2014 delivery announced today
· Project Fusion, our new product development programme, progressing to schedule
· Further market share gain for the Milk-Rite IP-MV liner
· Dairy sales and distribution facility established in China
Peter Slabbert, Chief Executive commented:
"The Protection & Defence business will continue to benefit from the security of the long term DoD contract and increased market share in the US homeland security and foreign military markets. In the short term, however, visibility and timing of filter orders from the DoD and foreign military orders remains limited. We are accelerating investment in Project Fusion's new products and technologies which will support an expanded product range. We also expect to continue to deliver further operational efficiencies.
In Dairy we remain well positioned in a market with long term growth potential. The market is stable, our cost base is appropriate and we have opportunities to further enhance profitability through our strong Milk-Rite brand, our distribution capability and by developing further innovative new products.
We are delivering our strategy. The Board remains confident that the Group can continue to progress and, as last year, expects stronger revenues in the second half."
Avon Rubber p.l.c. |
|
|
|
|
|
Peter Slabbert, Chief Executive |
Today: |
020 7067 0700 |
Andrew Lewis, Group Finance Director |
Thereafter: |
01225 896 870 |
|
|
|
Fiona Stewart, Corporate Communications Executive |
01225 896 835 |
|
|
|
|
Weber Shandwick Financial |
|
|
Nick Oborne |
|
020 7067 0700 |
Stephanie Badjonat |
|
|
NOTES TO EDITORS: Avon Rubber p.l.c. is a world leader in the design, test and manufacture of advanced Chemical, Biological, Radiological and Nuclear (CBRN) respiratory protection solutions to the worlds military, law enforcement, first responder, emergency services, fire and industrial markets. Avon has a unique capability in CBRN protection based on a range of advanced CBRN technologies in respirator design, filtration and compressed air breathing apparatus. This enables Avon to develop specialised solutions that take full account of user requirements. Avon also owns a world leading dairy business manufacturing liners and tubing for the automated milking process. For further information please visit the Group's website www.avon‐rubber.com
Interim Management Report
INTRODUCTION
Avon has made good strategic progress during the first half of 2012, establishing the first Dairy sales and distribution facility in emerging markets in China and continuing our Protection & Defence programme of new product development, Project Fusion. These developments and our strong balance sheet underpin the medium term progress of the Group.
The Protection & Defence business has benefited from increased DoD mask system orders and better operational performance. Reflecting the timing of the shipment of large "impact" orders, which generally require export licences and overseas delivery, non-DoD business has been slightly weaker than the strong comparable period last year. However, non-DoD order intake overall has been comparatively strong at £22.4m (2011: £5.4m). In particular, we have recently received our largest ever single order from the Middle East worth £14.7m; the majority of revenues from this contract are expected to benefit our 2013 and 2014 financial years.
The profitability of our Dairy business has improved significantly year on year, reflecting stable market conditions and the continued growth of our higher margin IP-MV liner, which has now achieved a greater than 10% market share in North America. This success has allowed us to add capability to the division's management team and to invest in China, which together added £0.3m to overheads in the period, or £0.8m on an annualised basis.
GROUP RESULTS
Group revenue at £49.6m (2011: £48.0m) was up by 3%, with growth coming from both divisions.
Foreign exchange translation has not had a material impact on our results for this half year as the $/£ average rate of $1.58 was similar to the $1.59 which prevailed in the same period last year.
The Group made an operating profit of £5.0m (2011: £4.8m), an increase of 3%. Earnings before Interest, Tax, Depreciation and Amortisation ('EBITDA') were £7.2m (2011: £7.1m).
Net finance costs reduced to £0.1m (2011: £0.2m) reflecting the continuation of the lower level of core borrowings and the improved cost of funds negotiated last year as part of our longer term financing agreement.
The non-cash other finance expense was constant at £0.2m (2011: £0.2m). Increased asset values since 30 September 2011, as our pension scheme's investment strategy continues to perform well in difficult markets, have been offset by higher liabilities as the discount rate, which is linked to AA corporate bond yields, fell.
Profit before tax was £4.6m (2011: £4.4m) and after a tax charge of £1.3m (2011: £1.3m), an effective rate of 29% (2011: 30%), the Group recorded a profit for the period after tax of £3.3m (2011: £3.1m). The reduced tax rate reflects a combination of the geographical split of taxable profits and the lower other finance expense relating to the pension scheme. Basic earnings per share were up 5% at 11.3p (2011: 10.8p) and fully diluted earnings per share were up 8% at 10.8p (2011: 10.0p).
NET DEBT AND CASHFLOW
Net debt decreased from £11.8m at the 2011 year end to £9.8m at 31 March 2012. This has been driven by a 126% conversion of operating profit to operating cash inflow, offset by capital expenditure of £3.6m (2011: £2.1m) as our investment in Project Fusion continues and the establishment of our Dairy sales and distribution facility in China was completed.
Total bank facilities at 31 March 2012 were £24.1m, the majority of which are US$ denominated and committed to 30 March 2015.
PROTECTION & DEFENCE
Revenue for the division was £33.2m (2011: £32.7m).
Sales of our M50 military respirator were in line with forecast in the first half of the year, up 30% on 2011, with deliveries of approximately half of the 2012 committed order book of 192,000 mask systems.
We announced on 20 December 2011 the award of a five year IDIQ filter supply contract. The delay in our customer putting this contract vehicle in place restricted our ability to ship filter spares in the first quarter and therefore, as expected, the volume of filters shipped in the period is down. We now have two contract vehicles in place with the DoD which allow them to procure filter spares; we remain a sole source supplier until the end of 2013 and believe the end user demand for this consumable product will continue to grow as fielding of the mask accelerates, albeit in the current US procurement environment short term visibility of orders remains a challenge.
In addition to DoD business, orders for our respiratory protection products from US homeland security and foreign military customers continued to grow including, as indicated above, the receipt of our largest ever single commercial order from the Middle East, for delivery primarily in 2013 and 2014.
The first half of 2011 saw significant sales to Saudi Arabia, Kuwait, France and our first foreign military sale through the US DoD. That level of 'impact' sales has not been repeated so far in 2012, but we remain confident that Avon's respiratory protection products are the product of choice in defence and homeland security markets around the world and we expect the proportion of revenues from these sources to continue to grow over the medium term.
As a result of the lower level of these higher margin impact sales and despite improved operating efficiencies, operating profit was down 7% at £3.0m (2011: £3.2m) and EBITDA was down 6% at £5.0m (2011: £5.3m).
DAIRY
Revenues for the Dairy business were up 7% at £16.4m (2011: £15.4m) which generated an operating profit of £2.9m (2011: £2.5m). EBITDA was £3.2m (2011: £2.7m), giving a return on sales of 19.2%, up from 17.6% in 2011.
The Dairy business benefited from a stable market and the success of the ground breaking impulse mouthpiece vented liner ('IP-MV') which was launched in the second half of 2010 and has seen continued success in 2012. This delivers a higher margin sales mix which has more than offset lower OE sales in the US and further investment in our growth strategy, particularly in emerging markets.
Our sales and distribution facility in China opened in February 2012 and we now have a team of nine staff in place. Our first sales were achieved at modest levels in March 2012 and the focus of the remainder of the year is on establishing a robust distribution network.
RETIREMENT BENEFIT OBLIGATIONS
The IAS 19 valuation of the Group's UK retirement benefit obligations has moved from a surplus of £0.3m at 30 September 2011 to a surplus of £2.0m as at 31 March 2012.
DIVIDENDS
The final dividend for the 2011 financial year of 2.0p per ordinary share was paid to shareholders on 9 March 2012 and absorbed £588,000 of shareholders' funds.
Subsequent to the period end, the Board approved an interim dividend of 1.2p per ordinary share for 2012, an increase of 20% on the 2011 interim dividend. This will be paid on 7 September 2012 to shareholders on the register on 10 August 2012. It is expected to absorb £353,000 of shareholders' funds and there are no corporation tax consequences.
BOARD CHANGES
As previously announced, the Rt. Hon. Sir Richard Needham stood down as Chairman of the Board at the Annual General Meeting on 2 February 2012 and was succeeded by David Evans. Sir Richard will remain as a non-executive Director until the AGM in 2013.
OUTLOOK
The Protection & Defence business will continue to benefit from the security of the long term DoD contract and increased market share in the US homeland security and foreign military markets. In the short term however, the visibility and timing of filter orders from the DoD and foreign military orders remains limited. We are accelerating investment in new products and technologies and expect to continue to deliver further operational efficiencies.
In Dairy we remain well positioned in a market with long term growth potential. The market is stable, our cost base is appropriate and we have opportunities to enhance profitability through our strong Milk-Rite brand, our distribution capability and by developing further innovative new products.
We are delivering our strategy. The Board remains confident that the Group can continue to progress and, as last year, expects stronger revenues in the second half.
Peter Slabbert Chief Executive 2 May 2012 |
Andrew Lewis Group Finance Director 2 May 2012 |
Statement of Directors' Responsibilities
The Directors confirm that this condensed consolidated interim financial information has been prepared in accordance with the International Accounting Standard 34, 'Interim Financial Reporting' as adopted by the European Union, and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8R, namely:
• an indication of important events that have occurred during the first six months and their impact on the condensed consolidated interim financial information, and a description of the principal risks and uncertainties for the remaining six months of the financial year; and
• material related party transactions in the first six months and any material changes in the related‐party transactions described in the last annual report
The Directors are as listed on page 21 of the 2011 Annual Report.
Forward‐looking statements
Certain statements in this half year report are forward‐looking. Although the Group believes that the expectations reflected in these forward‐looking statements are reasonable, we can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward‐looking statements.
We undertake no obligation to update any forward‐looking statements whether as a result of new information, future events or otherwise.
Company website
The interim statement is available on the Company's website at http://interim.avon‐rubber.com. The maintenance and integrity of the website is the responsibility of the Directors. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.
Miles Ingrey-Counter Company Secretary 2 May 2012 |
Consolidated Statement of Comprehensive Income |
||||
|
|
Half year to |
Half year to |
Year to |
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
Note |
£'000 |
£'000 |
£'000 |
|
|
|
|
|
Revenue |
4 |
49,632 |
48,009 |
107,600 |
Cost of sales |
|
(35,586) |
(34,296) |
(77,892) |
Gross profit |
|
14,046 |
13,713 |
29,708 |
Distribution costs |
|
(2,737) |
(2,483) |
(4,832) |
Administrative expenses |
|
(6,355) |
(6,419) |
(13,740) |
Operating profit |
4 |
4,954 |
4,811 |
11,136 |
|
|
|
|
|
Operating profit is analysed as: |
|
|
|
|
Before depreciation and amortisation |
|
7,236 |
7,125 |
15,723 |
Depreciation and amortisation |
|
(2,282) |
(2,314) |
(4,587) |
Operating profit |
|
4,954 |
4,811 |
11,136 |
|
|
|
|
|
Finance income |
5 |
- |
5 |
5 |
Finance costs |
5 |
(144) |
(227) |
(486) |
Other finance expense |
5 |
(198) |
(229) |
(443) |
Profit before taxation |
|
4,612 |
4,360 |
10,212 |
Taxation |
6 |
(1,337) |
(1,308) |
(3,094) |
Profit for the period |
|
3,275 |
3,052 |
7,118 |
|
|
|
|
|
|
|
|
|
|
Other comprehensive income |
|
|
|
|
Actuarial gain recognised in retirement benefit schemes |
|
1,522 |
7,052 |
5,738 |
Net exchange differences offset in reserves |
|
(613) |
(340) |
358 |
Other comprehensive income for the period, net of taxation |
|
909 |
6,712 |
6,096 |
|
|
|
|
|
Total comprehensive income for the period |
|
4,184 |
9,764 |
13,214 |
|
|
|
|
|
Earnings per share |
|
|
|
|
Basic |
8 |
11.3p |
10.8p |
25.2p |
Diluted |
8 |
10.8p |
10.0p |
23.3p |
Consolidated Balance Sheet |
|
|
|
|
|
|
As at |
As at |
As at |
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
Note |
£'000 |
£'000 |
£'000 |
Assets |
|
|
|
|
Non-current assets |
|
|
|
|
Intangible assets |
|
11,147 |
9,058 |
10,469 |
Property, plant and equipment |
|
16,737 |
16,379 |
16,718 |
Retirement benefit assets |
|
1,981 |
900 |
280 |
|
|
29,865 |
26,337 |
27,467 |
|
|
|
|
|
Current assets |
|
|
|
|
Inventories |
|
11,414 |
19,585 |
10,679 |
Trade and other receivables |
|
17,498 |
12,248 |
18,461 |
Derivative financial instruments |
|
55 |
140 |
- |
Cash and cash equivalents |
12 |
80 |
1,374 |
559 |
|
|
29,047 |
33,347 |
29,699 |
|
|
|
|
|
Liabilities |
|
|
|
|
Current liabilities |
|
|
|
|
Borrowings |
12 |
688 |
- |
392 |
Trade and other payables |
|
14,701 |
16,952 |
15,220 |
Derivative financial instruments |
|
- |
- |
166 |
Dividends payable |
7 |
- |
424 |
- |
Provisions for liabilities and charges |
9 |
567 |
1,622 |
567 |
Current tax liabilities |
|
3,630 |
1,904 |
2,040 |
|
|
19,586 |
20,902 |
18,385 |
|
|
|
|
|
Net current assets |
|
9,461 |
12,445 |
11,314 |
|
|
|
|
|
Non-current liabilities |
|
|
|
|
Borrowings |
12 |
9,165 |
15,302 |
11,983 |
Deferred tax liabilities |
|
2,810 |
2,622 |
2,985 |
Provisions for liabilities and charges |
9 |
2,536 |
2,672 |
2,641 |
|
|
14,511 |
20,596 |
17,609 |
Net assets |
|
24,815 |
18,186 |
21,172 |
|
|
|
|
|
Shareholders' equity |
|
|
|
|
Ordinary shares |
10 |
30,723 |
30,723 |
30,723 |
Share premium account |
10 |
34,708 |
34,708 |
34,708 |
Capital redemption reserve |
|
500 |
500 |
500 |
Translation reserve |
|
(248) |
(333) |
365 |
Accumulated losses |
|
(40,868) |
(47,412) |
(45,124) |
Total equity |
|
24,815 |
18,186 |
21,172 |
Consolidated Cash Flow Statement |
|
|
|
|
|
|
Half year to |
Half year to |
Year to |
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
Note |
£'000 |
£'000 |
£'000 |
Cash flows from operating activities |
11 |
|
|
|
Cash generated from continuing operations |
|
6,225 |
1,608 |
11,974 |
Cash used in discontinued operations |
|
- |
(322) |
(1,557) |
Cash generated from operations |
|
6,225 |
1,286 |
10,417 |
Finance income received |
|
- |
5 |
5 |
Finance costs paid |
|
(153) |
(301) |
(476) |
Retirement benefit deficit recovery contributions |
|
(206) |
(238) |
(869) |
Tax received/(paid) |
|
159 |
(185) |
(1,542) |
Net cash generated from operating activities |
|
6,025 |
567 |
7,535 |
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
Proceeds from sale of property, plant and equipment |
|
- |
- |
17 |
Purchase of property, plant and equipment |
|
(1,922) |
(882) |
(2,406) |
Purchase of intangible assets |
|
(1,707) |
(1,202) |
(3,266) |
Net cash used in investing activities |
|
(3,629) |
(2,084) |
(5,655) |
|
|
|
|
|
Cash flows from financing activities |
|
|
|
|
Net movements in loans |
|
(2,583) |
2,315 |
(1,334) |
Dividends paid to shareholders |
|
(588) |
- |
(706) |
Purchase of own shares |
|
- |
- |
(250) |
Net cash (used in)/generated from financing activities |
|
(3,171) |
2,315 |
(2,290) |
|
|
|
|
|
Net (decrease)/increase in cash, cash equivalents and bank overdrafts |
|
(775) |
798 |
(410) |
Cash, cash equivalents and bank overdrafts at beginning of the year |
|
167 |
577 |
577 |
Effects of exchange rate changes |
|
- |
(1) |
- |
Cash, cash equivalents and bank overdrafts at end of the period |
12 |
(608) |
1,374 |
167 |
Consolidated Statement of Changes in Equity |
|
|
|
|||
|
|
|
|
|
|
|
|
|
Share |
Share |
Other |
Accumulated |
|
|
|
capital |
premium |
reserves |
losses |
Total |
|
Note |
£'000 |
£'000 |
£'000 |
£'000 |
£'000 |
At 1 October 2010 |
|
30,723 |
34,708 |
507 |
(57,161) |
8,777 |
Profit for the period |
|
- |
- |
- |
3,052 |
3,052 |
Unrealised exchange differences on overseas investments |
|
- |
- |
(340) |
- |
(340) |
Actuarial gain recognised in retirement benefit scheme |
|
- |
- |
- |
7,052 |
7,052 |
Total comprehensive income/(expense) for the period |
|
- |
- |
(340) |
10,104 |
9,764 |
Dividends approved |
|
|
|
|
(424) |
(424) |
Movement in respect of employee share schemes |
|
- |
- |
- |
69 |
69 |
At 31 March 2011 |
|
30,723 |
34,708 |
167 |
(47,412) |
18,186 |
Profit for the period |
|
- |
- |
- |
4,066 |
4,066 |
Unrealised exchange differences on overseas investments |
|
- |
- |
698 |
- |
698 |
Actuarial loss recognised in retirement benefit scheme |
|
- |
- |
- |
(1,314) |
(1,314) |
Total comprehensive income for the period |
|
- |
- |
698 |
2,752 |
3,450 |
Dividends paid |
|
- |
- |
- |
(282) |
(282) |
Purchase of shares by the employee benefit trust |
|
- |
- |
- |
(250) |
(250) |
Movement in respect of employee share schemes |
|
- |
- |
- |
68 |
68 |
At 30 September 2011 |
|
30,723 |
34,708 |
865 |
(45,124) |
21,172 |
Profit for the period |
|
- |
- |
- |
3,275 |
3,275 |
Unrealised exchange differences on overseas investments |
|
- |
- |
(613) |
- |
(613) |
Actuarial gain recognised in retirement benefit scheme |
|
- |
- |
- |
1,522 |
1,522 |
Total comprehensive income/(expense) for the period |
|
- |
- |
(613) |
4,797 |
4,184 |
Dividends paid |
7 |
- |
- |
- |
(588) |
(588) |
Movement in respect of employee share schemes |
|
- |
- |
- |
47 |
47 |
At 31 March 2012 |
|
30,723 |
34,708 |
252 |
(40,868) |
24,815 |
Notes to the Interim Financial Statements
1. General information
The company is a limited liability company incorporated and domiciled in the UK. The address of its registered office is Hampton Park West, Semington Road, Melksham, Wiltshire, SN12 6NB.
The company has its primary listing on the London Stock Exchange.
This condensed consolidated interim financial information was approved for issue on 2 May 2012.
These interim financial results do not comprise statutory accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 September 2011 were approved by the Board of Directors on 23 November 2011 and delivered to the Registrar of Companies. The report of the auditors on those accounts was unqualified, did not contain an emphasis of matter paragraph and did not contain any statement under Section 498 of the Companies Act 2006.
2. Basis of preparation
This condensed consolidated interim financial information for the half-year ended 31 March 2012 has been prepared in accordance with the Disclosure and Transparency rules of the Financial Services Authority and with IAS 34, 'Interim financial reporting' as adopted by the European Union. These interim financial results should be read in conjunction with the annual financial statements for the year ended 30 September 2011, which have been prepared in accordance with IFRSs as adopted by the European Union.
Having considered the Group's funding position, budgets for 2012 and three year plan, the Directors have formed a judgment that there is a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason the Directors continue to adopt the going concern basis in preparing the condensed consolidated financial information.
3. Accounting policies
The accounting policies adopted are consistent with those of the annual financial statements for the year ended 30 September 2011, as described in those financial statements.
Recent accounting developments
The following standards, amendments and interpretations have been issued by the International Accounting Standards Board (IASB) or by the International Financial Reporting Interpretations Committee (IFRIC) but have not yet been adopted. Subject to endorsement by the European Union, these will be adopted in future periods. The Group's approach to these is as follows:
a) Standards, amendments and interpretations effective in 2012
The following standards, amendments and interpretations have been adopted in preparing the condensed consolidated half-yearly financial information and will be adopted for the year ended 30 September 2012:
- IAS 24 (revised), 'Related party disclosures'
- Amendment to IFRIC 14, 'The limit on a defined benefit asset, minimum funding requirements and their interaction'
- Annual improvements 2010
The adoption of these amendments has not had a material impact on the half-yearly financial information.
b) Standards, amendments and interpretations to existing standards effective in 2012 but not relevant to the Group
- Amendments to IFRS 1, 'First time adoption' on fixed dates and hyperinflation
- Amendment to IFRS 7 'Financial Instruments: Disclosures - Transfers of Financial Assets'
c) Standards, amendments and interpretations to existing standards issued but not yet effective in 2012 and not early adopted.
- IFRS 9, 'Financial instruments'
- IFRS 10, 'Consolidated financial statements'
- IFRS 11, 'Joint arrangements'
- IFRS 12, 'Disclosure of interests in other entities'
- IFRS 13, 'Fair value measurement'
- IAS 27 (revised), 'Separate financial statements'
- IAS 28 (revised), 'Associates and joint ventures'
- Amendment to IAS 12, 'Income taxes'
- Amendment to IAS 1, 'Financial statement presentation'
- Amendment to IAS 19, 'Employee benefits'
4. Segment information |
|
|
|
|
||||
|
|
|
|
|
||||
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Board of Directors and the Group Executive team. |
|
|||||||
|
||||||||
|
||||||||
|
|
|
|
|
||||
The Group has two clearly defined business segments, Protection & Defence and Dairy, and operates out of the UK and the USA. |
|
|||||||
|
||||||||
|
|
|
|
|
|
|||
Business segments |
|
|
|
|
|
|||
Half year to 31 March 2012 (Unaudited) |
|
|
|
|
|
|||
|
Protection & Defence |
|
|
|
|
|||
|
Dairy |
Unallocated |
Group |
|
||||
|
£'000 |
£'000 |
£'000 |
£'000 |
|
|||
Revenue |
33,196 |
16,436 |
|
49,632 |
|
|||
|
|
|
|
|
|
|||
Segment result before depreciation and amortisation |
5,000 |
3,159 |
(923) |
7,236 |
|
|||
Depreciation of property, plant and equipment |
(1,227) |
(240) |
(20) |
(1,487) |
|
|||
Amortisation of intangibles |
(781) |
(14) |
- |
(795) |
|
|||
Segment result |
2,992 |
2,905 |
(943) |
4,954 |
|
|||
Finance income |
|
|
- |
- |
|
|||
Finance costs |
|
|
(144) |
(144) |
|
|||
Other finance expense |
|
|
(198) |
(198) |
|
|||
Profit before taxation |
2,992 |
2,905 |
(1,285) |
4,612 |
|
|||
Taxation |
|
|
(1,337) |
(1,337) |
|
|||
Profit for the period |
2,992 |
2,905 |
(2,622) |
3,275 |
|
|||
|
|
|
|
|
|
|||
Half year to 31 March 2011 (Unaudited) |
|
|
|
|
|
|||
|
Protection & Defence |
|
|
|
|
|||
|
Dairy |
Unallocated |
Group |
|
||||
|
£'000 |
£'000 |
£'000 |
£'000 |
|
|||
Revenue |
32,659 |
15,350 |
|
48,009 |
|
|||
|
|
|
|
|
|
|||
Segment result before depreciation and amortisation |
5,311 |
2,695 |
(881) |
7,125 |
|
|||
Depreciation of property, plant and equipment |
(1,137) |
(191) |
(16) |
(1,344) |
|
|||
Amortisation of intangibles |
(969) |
- |
(1) |
(970) |
|
|||
Segment result |
3,205 |
2,504 |
(898) |
4,811 |
|
|||
Finance income |
|
|
5 |
5 |
|
|||
Finance costs |
|
|
(227) |
(227) |
|
|||
Other finance expense |
|
|
(229) |
(229) |
|
|||
Profit before taxation |
3,205 |
2,504 |
(1,349) |
4,360 |
|
|||
Taxation |
|
|
(1,308) |
(1,308) |
|
|||
Profit for the period |
3,205 |
2,504 |
(2,657) |
3,052 |
|
|||
|
|
|
|
|
|
|||
Year to 30 September 2011 (Audited) |
|
|
|
|
|
|||
|
Protection & Defence |
|
|
|
|
|||
|
Dairy |
Unallocated |
Group |
|
||||
|
£'000 |
£'000 |
£'000 |
£'000 |
|
|||
Revenue |
77,438 |
30,162 |
|
107,600 |
|
|||
|
|
|
|
|
|
|||
Segment result before depreciation and amortisation |
11,630 |
5,911 |
(1,818) |
15,723 |
|
|||
Depreciation of property, plant and equipment |
(2,396) |
(387) |
(33) |
(2,816) |
|
|||
Amortisation of intangibles |
(1,741) |
(28) |
(2) |
(1,771) |
|
|||
Segment result |
7,493 |
5,496 |
(1,853) |
11,136 |
|
|||
Finance income |
|
|
5 |
5 |
|
|||
Finance costs |
|
|
(486) |
(486) |
|
|||
Other finance expense |
|
|
(443) |
(443) |
|
|||
Profit before taxation |
7,493 |
5,496 |
(2,777) |
10,212 |
|
|||
Taxation |
|
|
(3,094) |
(3,094) |
|
|||
Profit for the year |
7,493 |
5,496 |
(5,871) |
7,118 |
|
|||
|
|
|
|
|
|
|||
Revenue by origin |
|
|
|
|
|
|||
|
|
Half year to |
Half year to |
Year to |
|
|||
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
|
|||
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
|
|||
|
|
£'000 |
£'000 |
£'000 |
|
|||
UK |
|
7,282 |
6,804 |
14,847 |
|
|||
USA |
|
42,350 |
41,205 |
92,753 |
|
|||
|
|
49,632 |
48,009 |
107,600 |
|
|||
|
|
|
|
|
|
|||
Segment assets in the UK and USA were £12.2m and £46.7m respectively (30 September 2011: £9.9m and £47.3m, 31 March 2011: £11.1m and £48.6m). |
|
|||||||
|
5. Finance income and costs |
|
|
|
|
||||||
|
|
Half year to |
Half year to |
Year to |
||||||
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
||||||
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
||||||
|
|
£'000 |
£'000 |
£'000 |
||||||
Interest payable on bank loans and overdrafts |
|
(144) |
(227) |
(486) |
||||||
Finance income |
|
- |
5 |
5 |
||||||
|
|
(144) |
(222) |
(481) |
||||||
|
|
|
|
|
||||||
Other finance expense |
|
|
|
|
||||||
|
|
Half year to |
Half year to |
Year to |
||||||
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
||||||
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
||||||
|
|
£'000 |
£'000 |
£'000 |
||||||
Interest cost: UK defined benefit pension scheme |
|
(6,801) |
(6,638) |
(13,277) |
||||||
Expected return on plan assets: UK defined benefit pension scheme |
|
6,780 |
6,612 |
13,226 |
||||||
Provisions: Unwinding of discount |
|
(177) |
(203) |
(392) |
||||||
|
|
(198) |
(229) |
(443) |
||||||
|
|
|
|
|
||||||
6. Taxation |
|
|
|
|
||||||
|
|
Half year to |
Half year to |
Year to |
||||||
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
||||||
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
||||||
|
|
£'000 |
£'000 |
£'000 |
||||||
United Kingdom |
|
- |
- |
- |
||||||
Overseas |
|
1,337 |
1,308 |
3,094 |
||||||
|
|
1,337 |
1,308 |
3,094 |
||||||
|
|
|
|
|
||||||
The effective tax rate for the period is 29% (2011: 30%). The adjusted effective tax rate is 28% (2011: 29%), defined as the tax charge divided by the profit before tax, excluding the charge relating to other finance expense. |
||||||||||
|
|
|
|
|
||||||
7. Dividends |
|
|
|
|
||||||
|
|
|
|
|
||||||
On 2 February 2012, the shareholders approved a final dividend of 2.0p per qualifying ordinary share in respect of the year ended 30 September 2011. This was paid on 9 March 2012 absorbing £588,000 of shareholders' funds. |
||||||||||
|
|
|
|
|
||||||
The Board of Directors have approved an interim dividend of 1.2p (2011: 1.0p) per qualifying ordinary share in respect of the year ended 30 September 2012. This will be paid on 7 September 2012 to shareholders on the register at the close of business on 10 August 2012. In accordance with accounting standards this dividend has not been provided for and there are no corporation tax consequences. It will be recognised in shareholders' funds in the year to 30 September 2012 and is expected to absorb £353,000 (2011: £282,000) of shareholders' funds. |
||||||||||
8. Earnings per share |
|
|
|
|
||||||
Basic earnings per share is based on a profit attributable to ordinary shareholders of £3,275,000 (2011: £3,052,000) and 28,893,000 (2011: 28,286,000) ordinary shares being the weighted average of the shares in issue during the period. |
||||||||||
|
|
|
|
|
||||||
The company has 1,510,000 (5.2%) (2011:2,375,000 (8.4%)) dilutive potential ordinary shares in respect of the Performance Share Plan. |
||||||||||
|
|
|
|
|
||||||
9. Provisions for liabilities and charges |
|
|
|
|
||||||
|
|
|
|
Property |
||||||
|
|
|
|
obligations |
||||||
|
|
|
|
£'000 |
||||||
Balance at 30 September 2011 |
|
|
|
3,208 |
||||||
Payments in the period |
|
|
|
(282) |
||||||
Unwinding of discount |
|
|
|
177 |
||||||
At 31 March 2012 |
|
|
|
3,103 |
||||||
|
|
|
|
|
||||||
|
|
|
|
|
||||||
10. Share Capital |
|
|
|
|
||||||
|
|
Half year to |
Half year to |
Year to |
||||||
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
||||||
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
||||||
|
|
|
|
|
||||||
Number of shares (thousands) |
|
30,723 |
30,723 |
30,723 |
||||||
|
|
|
|
|
||||||
Ordinary shares (£'000) |
|
30,723 |
30,723 |
30,723 |
||||||
|
|
|
|
|
||||||
Share premium (£'000) |
|
34,708 |
34,708 |
34,708 |
||||||
11. Cash generated from operations |
|
|
|
|
||||||
|
|
Half year to |
Half year to |
Year to |
||||||
|
|
31 Mar 12 |
31 Mar 11 |
30 Sep 11 |
||||||
|
|
(Unaudited) |
(Unaudited) |
(Audited) |
||||||
|
|
£'000 |
£'000 |
£'000 |
||||||
Continuing operations |
|
|
|
|
||||||
Profit for the financial period |
|
3,275 |
3,052 |
7,118 |
||||||
Adjustments for: |
|
|
|
|
||||||
Taxation |
|
1,337 |
1,308 |
3,094 |
||||||
Depreciation |
|
1,487 |
1,344 |
2,816 |
||||||
Amortisation of intangible assets |
|
795 |
970 |
1,771 |
||||||
Net finance expense |
|
144 |
222 |
481 |
||||||
Other finance expense |
|
198 |
229 |
443 |
||||||
Loss/(profit) on disposal of property, plant and equipment |
|
23 |
- |
(1) |
||||||
Movements in working capital and provisions |
|
(987) |
(5,436) |
(3,885) |
||||||
Other movements |
|
(47) |
(81) |
137 |
||||||
Cash generated from continuing operations |
|
6,225 |
1,608 |
11,974 |
||||||
|
|
|
|
|
||||||
Discontinued operations |
|
|
|
|
||||||
Movements in working capital and provisions |
|
- |
(322) |
(1,557) |
||||||
Cash used in discontinued operations |
|
- |
(322) |
(1,557) |
||||||
Cash generated from operations |
|
6,225 |
1,286 |
10,417 |
||||||
|
|
|
|
|
||||||
12. Analysis of net debt |
|
|
|
|
||||||
|
As at |
|
Exchange |
As at |
||||||
|
30 Sep 11 |
Cash flow |
movements |
31 Mar 12 |
||||||
|
£'000 |
£'000 |
£'000 |
£'000 |
||||||
Cash at bank and in hand |
559 |
(479) |
- |
80 |
||||||
Overdrafts |
(392) |
(296) |
- |
(688) |
||||||
Net cash and cash equivalents |
167 |
(775) |
- |
(608) |
||||||
Debt due in more than 1 year |
(11,983) |
2,583 |
235 |
(9,165) |
||||||
|
(11,816) |
1,808 |
235 |
(9,773) |
||||||
|
|
|
|
|
||||||
Borrowing facilities |
|
Total |
|
|
||||||
|
|
facility |
Utilised |
Undrawn |
||||||
|
|
£'000 |
£'000 |
£'000 |
||||||
United Kingdom |
|
14,701 |
5,287 |
9,414 |
||||||
North America |
|
9,002 |
4,566 |
4,436 |
||||||
Utilised in respect of guarantees |
|
386 |
386 |
- |
||||||
|
|
24,089 |
10,239 |
13,850 |
||||||
|
|
|
|
|
||||||
The above facilities are with Barclays Bank and Comerica Bank. The Barclays facility comprises a revolving credit facility of £5m and $15.5m and expires on 30 March 2015. The Comerica facility is a $15m revolving credit facility and expires on 30 September 2014. These facilities are priced on average at the appropriate currency LIBOR plus a margin of 2% and include financial covenants, which are measured on a quarterly basis and were complied with during the period.
|
||||||||||
|
Fair value of financial instruments
The fair value of forward exchange contracts is determined by using valuation techniques using period end spot rates, adjusted for the forward points to the contract's value date.
13. Exchange rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
The following significant exchange rates applied during the period. |
|
|
||||
|
|
|
|
|
|
|
|
Average rate |
Closing rate |
Average rate |
Closing rate |
Average rate |
Closing rate |
|
H1 2012 |
H1 2012 |
H1 2011 |
H1 2011 |
FY 2011 |
FY 2011 |
US Dollar |
1.575 |
1.598 |
1.589 |
1.603 |
1.600 |
1.558 |
Euro |
1.182 |
1.200 |
1.167 |
1.133 |
1.156 |
1.161 |
|
|
|
|
|
|
|
14. Principal risks and uncertainties
The principal risks and uncertainties impacting the Group are described on page 19 of our Annual Report 2011 and remain unchanged at 31 March 2012.
They include: quality and product recall, supply chain interruption, product development, competitor threat, talent management, customer dependency and non-compliance with legislation.